FITC Anti-Human CD29 Antibody[TS2/16.2.1]

Introducing the FITC Anti-Human CD29 Antibody [TS2/16.2.1], a highly reliable and efficient tool for immunofluorescence applications. This antibody, derived from the TS2/16.2.1 clone, specifically targets the CD29 antigen found on human cells.

With its exceptional specificity and sensitivity, this FITC-conjugated antibody enables accurate identification and analysis of CD29 expression in various cell types. Its fluorescence properties allow for easy visualization and quantification of CD29-positive cells, facilitating comprehensive research in fields such as immunology, cell biology, and cancer research.

The FITC Anti-Human CD29 Antibody [TS2/16.2.1] exhibits outstanding performance in immunofluorescence assays, delivering consistent and reproducible results. Its high affinity for CD29 ensures minimal background noise, enabling precise detection and characterization of CD29-expressing cells.

This antibody is manufactured using state-of-the-art techniques, ensuring batch-to-batch consistency and reliability. Rigorous quality control measures guarantee its purity, functionality, and stability, providing researchers with a dependable tool for their experiments.

The FITC Anti-Human CD29 Antibody [TS2/16.2.1] is supplied in a convenient and user-friendly format, allowing for easy integration into existing laboratory protocols. Its optimized formulation ensures optimal performance and minimal non-specific binding, enhancing experimental accuracy and efficiency.

Choose the FITC Anti-Human CD29 Antibody [TS2/16.2.1] for your immunofluorescence studies and unlock new insights into CD29-mediated cellular processes. Trust in its exceptional quality and performance to advance your research endeavors.